Rigel Pharmaceuticals (RIGL)

$25.44 -0.94 (-3.56%)
Market Cap 479.37M
Revenue (ttm) 294.28M
Net Income (ttm) 367.02M
EPS (ttm) N/A
PE Ratio 3.99
Forward PE 6.10
Profit Margin 124.72%
Debt to Equity Ratio 0.06
Volume 373,181
Avg Vol 388,764
Day's Range N/A - N/A
Shares Out 18.47M
Stochastic %K 18%
Beta 1.10
Analysts Sell
Price Target $51.20

Company Profile

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (I...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 624 1100
Fax: 650 624 1101
Address:
611 Gateway Boulevard, Suite 900, South San Francisco, United States
mitgodog
mitgodog Mar. 18 at 8:16 PM
$RIGL Headed on vacation for 10 days i think I’ll just forget about RIGL and enjoy myself and when i get back see if we had some greens days!!
0 · Reply
christopher18
christopher18 Mar. 18 at 7:51 PM
$RIGL Reality is starting to set in that the market is going to hell over this Iran ordeal. I think the low 20s are in the near future. Still waiting for the run up post earnings! lol
0 · Reply
GO_DAWGS
GO_DAWGS Mar. 18 at 7:02 PM
$RIGL Raul Rocks! 😂😂😂😂
0 · Reply
Namhguab
Namhguab Mar. 18 at 6:52 PM
$RIGL 🖕 MM’s
0 · Reply
DosGatos
DosGatos Mar. 18 at 6:45 PM
$RIGL gonna lose 25, 500 mil MC long gone. Raul’s bank acct is overflowing yet ZERO share price appreciation in his VERY LONG tenure as CEO.
1 · Reply
MaxKlim
MaxKlim Mar. 18 at 6:44 PM
$RIGL https://www.thsna.org/virtual/?page=presentation&session_id=5&presentation_id=670&displayday=2&pagefrom=program&preview=
1 · Reply
MaxKlim
MaxKlim Mar. 18 at 6:43 PM
$RIGL https://www.abstractsonline.com/pp8/#!/21436/presentation/8921
1 · Reply
GO_DAWGS
GO_DAWGS Mar. 18 at 5:21 PM
$RIGL 😂😂😂😂
0 · Reply
Springsman72
Springsman72 Mar. 18 at 4:47 PM
$RIGL Seriously needs to be a buy back or something at least at this point... sheeesh. lol
1 · Reply
Namhguab
Namhguab Mar. 18 at 2:54 PM
$RIGL you’d never even know that we just had 41 percent growth year over year for the quarter. Simply amazing what is allowed to happen by the large institutionals. Pathetic really. Get rid of the SEC because they are nothing but wasted money
2 · Reply
Latest News on RIGL
Rigel Pharmaceuticals: Growing Where It Matters

Mar 10, 2026, 6:49 AM EDT - 8 days ago

Rigel Pharmaceuticals: Growing Where It Matters

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Mar 3, 2026, 8:32 PM EST - 14 days ago

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 3, 2026, 4:01 PM EST - 15 days ago

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update

Feb 24, 2026, 8:05 AM EST - 22 days ago

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update

Rigel Appoints Michael P. Miller to the Board of Directors

Feb 3, 2026, 8:05 AM EST - 6 weeks ago

Rigel Appoints Michael P. Miller to the Board of Directors

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026

Jan 26, 2026, 10:40 PM EST - 7 weeks ago

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026

Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 15, 2026, 3:25 AM EST - 2 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rigel Provides Business Update and 2026 Outlook

Jan 12, 2026, 8:05 AM EST - 2 months ago

Rigel Provides Business Update and 2026 Outlook

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Jan 9, 2026, 8:05 AM EST - 2 months ago

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:05 AM EST - 2 months ago

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rigel Pharma: Formulating A Game Plan For 2026

Jan 1, 2026, 4:41 AM EST - 2 months ago

Rigel Pharma: Formulating A Game Plan For 2026

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition

Dec 7, 2025, 9:30 AM EST - 3 months ago

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition

Rigel Pharma: Q3 Earnings Showcase Robust Growth

Nov 26, 2025, 8:15 AM EST - 4 months ago

Rigel Pharma: Q3 Earnings Showcase Robust Growth

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 8:05 AM EST - 4 months ago

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology

Nov 17, 2025, 8:05 AM EST - 4 months ago

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology

Rigel to Present at the Jefferies Global Healthcare Conference in London

Nov 12, 2025, 8:05 AM EST - 4 months ago

Rigel to Present at the Jefferies Global Healthcare Conference in London

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 8:06 PM EST - 4 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 4:01 PM EST - 4 months ago

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Nov 3, 2025, 9:05 AM EST - 4 months ago

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Oct 30, 2025, 2:20 PM EDT - 4 months ago

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Oct 29, 2025, 8:05 AM EDT - 5 months ago

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

Oct 8, 2025, 8:05 AM EDT - 5 months ago

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion

Sep 25, 2025, 10:53 PM EDT - 6 months ago

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion

Rigel to Participate in Upcoming September Investor Conferences

Aug 26, 2025, 8:05 AM EDT - 7 months ago

Rigel to Participate in Upcoming September Investor Conferences

Overlooked Stock: RIGL Nearly Doubles Stock in August

Aug 15, 2025, 5:20 PM EDT - 7 months ago

Overlooked Stock: RIGL Nearly Doubles Stock in August

The Big 3: OPEN, RIGL, JOBY

Aug 15, 2025, 12:00 PM EDT - 7 months ago

The Big 3: OPEN, RIGL, JOBY

JOBY OPEN

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout

Aug 13, 2025, 11:58 PM EDT - 7 months ago

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 8:02 PM EDT - 8 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 5, 2025, 4:01 PM EDT - 8 months ago

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update

Jul 29, 2025, 8:05 AM EDT - 8 months ago

Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update

Rigel to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 8:05 AM EDT - 10 months ago

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress

May 22, 2025, 5:20 PM EDT - 10 months ago

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum

May 7, 2025, 6:16 PM EDT - 11 months ago

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum

Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:13 PM EDT - 11 months ago

Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

May 6, 2025, 4:01 PM EDT - 11 months ago

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Apr 29, 2025, 8:05 AM EDT - 11 months ago

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability

Apr 4, 2025, 3:31 PM EDT - 1 year ago

Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Mar 27, 2025, 8:05 AM EDT - 1 year ago

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Rigel Appoints Mark W. Frohlich, M.D.

Mar 10, 2025, 8:05 AM EDT - 1 year ago

Rigel Appoints Mark W. Frohlich, M.D.

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 11:29 PM EST - 1 year ago

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 4, 2025, 4:01 PM EST - 1 year ago

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 25, 2025, 8:05 AM EST - 1 year ago

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

Jan 22, 2025, 8:05 AM EST - 1 year ago

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

Rigel Provides Business Update and 2025 Outlook

Jan 13, 2025, 8:05 AM EST - 1 year ago

Rigel Provides Business Update and 2025 Outlook

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Jan 9, 2025, 8:05 AM EST - 1 year ago

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 8:05 AM EST - 1 year ago

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents

Dec 30, 2024, 8:30 AM EST - 1 year ago

Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

Dec 9, 2024, 12:02 PM EST - 1 year ago

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

Dec 2, 2024, 8:05 AM EST - 1 year ago

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

Rigel to Present at the Jefferies London Healthcare Conference

Nov 12, 2024, 8:05 AM EST - 1 year ago

Rigel to Present at the Jefferies London Healthcare Conference

mitgodog
mitgodog Mar. 18 at 8:16 PM
$RIGL Headed on vacation for 10 days i think I’ll just forget about RIGL and enjoy myself and when i get back see if we had some greens days!!
0 · Reply
christopher18
christopher18 Mar. 18 at 7:51 PM
$RIGL Reality is starting to set in that the market is going to hell over this Iran ordeal. I think the low 20s are in the near future. Still waiting for the run up post earnings! lol
0 · Reply
GO_DAWGS
GO_DAWGS Mar. 18 at 7:02 PM
$RIGL Raul Rocks! 😂😂😂😂
0 · Reply
Namhguab
Namhguab Mar. 18 at 6:52 PM
$RIGL 🖕 MM’s
0 · Reply
DosGatos
DosGatos Mar. 18 at 6:45 PM
$RIGL gonna lose 25, 500 mil MC long gone. Raul’s bank acct is overflowing yet ZERO share price appreciation in his VERY LONG tenure as CEO.
1 · Reply
MaxKlim
MaxKlim Mar. 18 at 6:44 PM
$RIGL https://www.thsna.org/virtual/?page=presentation&session_id=5&presentation_id=670&displayday=2&pagefrom=program&preview=
1 · Reply
MaxKlim
MaxKlim Mar. 18 at 6:43 PM
$RIGL https://www.abstractsonline.com/pp8/#!/21436/presentation/8921
1 · Reply
GO_DAWGS
GO_DAWGS Mar. 18 at 5:21 PM
$RIGL 😂😂😂😂
0 · Reply
Springsman72
Springsman72 Mar. 18 at 4:47 PM
$RIGL Seriously needs to be a buy back or something at least at this point... sheeesh. lol
1 · Reply
Namhguab
Namhguab Mar. 18 at 2:54 PM
$RIGL you’d never even know that we just had 41 percent growth year over year for the quarter. Simply amazing what is allowed to happen by the large institutionals. Pathetic really. Get rid of the SEC because they are nothing but wasted money
2 · Reply
zajazdowicz
zajazdowicz Mar. 18 at 2:54 PM
$RIGL whats going on here do kurwy nędzy ?
0 · Reply
nnkr
nnkr Mar. 18 at 2:18 PM
$RIGL market conditions are not favorable for a recovery here. Energy price spikes, if prolonged, may trigger recession.
1 · Reply
Purplesabbath
Purplesabbath Mar. 18 at 2:03 PM
$RIGL since Raul became CEO in 2013, the stock price of Rigl today, HAS NOT CHANGED
1 · Reply
Flipcoin1982
Flipcoin1982 Mar. 17 at 10:31 PM
$RIGL why always this spikes outside trading hours @sec?!!!
1 · Reply
christopher18
christopher18 Mar. 17 at 6:35 PM
$RIGL To think this stock has lost almost 50% gains from the previous high is quite the eye opener!
0 · Reply
Gabriel1234
Gabriel1234 Mar. 17 at 5:10 PM
$RIGL Bigstock CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Mar. 17 at 4:16 PM
$RIGL
1 · Reply
DosGatos
DosGatos Mar. 17 at 3:18 PM
$RIGL well that was nice yesterday
2 · Reply
GO_DAWGS
GO_DAWGS Mar. 17 at 12:36 PM
$RIGL 😂😂😂😂
0 · Reply
nirok
nirok Mar. 16 at 7:56 PM
$RIGL hope we hear something about drug acquisition soon.
1 · Reply
DosGatos
DosGatos Mar. 16 at 7:25 PM
$RIGL hold 1% raul YOU CAN DO IT!
0 · Reply